27579316|t|MicroRNA Expression Signature in Degenerative Aortic Stenosis
27579316|a|Degenerative aortic stenosis, characterized by narrowing of the exit of the left ventricle of the heart, has become the most common valvular heart disease in the elderly. The aim of this study was to investigate the microRNA (miRNA) signature in degenerative AS. Through microarray analysis, we identified the miRNA expression signature in the tissue samples from healthy individuals (n = 4) and patients with degenerative AS (n = 4). Six miRNAs (hsa-miR-193a-3p, hsa-miR-29b-1-5p, hsa-miR-505-5p, hsa-miR-194-5p, hsa-miR-99b-3p, and hsa-miR-200b-3p) were overexpressed and 14 (hsa-miR-3663-3p, hsa-miR-513a-5p, hsa-miR-146b-5p, hsa-miR-1972, hsa-miR-718, hsa-miR-3138, hsa-miR-21-5p, hsa-miR-630, hsa-miR-575, hsa-miR-301a-3p, hsa-miR-636, hsa-miR-34a-3p, hsa-miR-21-3p, and hsa-miR-516a-5p) were downregulated in aortic tissue from AS patients. GeneSpring 13.1 was used to identify potential human miRNA target genes by comparing a 3-way comparison of predictions from TargetScan, PITA, and microRNAorg databases. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis were performed to identify potential pathways and functional annotations associated with AS. Twenty miRNAs were significantly differentially expressed between patients with AS samples and normal controls and identified potential miRNA targets and molecular pathways associated with this morbidity. This study describes the miRNA expression signature in degenerative AS and provides an improved understanding of the molecular pathobiology of this disease.
27579316	0	8	MicroRNA	T028	C2825314
27579316	9	29	Expression Signature	T169	C1704864
27579316	33	61	Degenerative Aortic Stenosis	T047	C0003507
27579316	62	90	Degenerative aortic stenosis	T047	C0003507
27579316	92	105	characterized	T052	C1880022
27579316	109	118	narrowing	T190	C3854333
27579316	126	130	exit	T082	C0337094
27579316	138	152	left ventricle	T023	C0225897
27579316	160	165	heart	T023	C0018787
27579316	194	216	valvular heart disease	T047	C0018824
27579316	224	231	elderly	T098	C0001792
27579316	237	240	aim	T078	C1947946
27579316	249	254	study	T062	C2603343
27579316	262	273	investigate	T169	C1292732
27579316	278	286	microRNA	T028	C2825314
27579316	288	293	miRNA	T028	C2825314
27579316	295	304	signature	T169	C1704864
27579316	308	323	degenerative AS	T047	C0003507
27579316	333	352	microarray analysis	T059	C1449575
27579316	357	367	identified	T080	C0205396
27579316	372	377	miRNA	T028	C2825314
27579316	378	398	expression signature	T169	C1704864
27579316	406	412	tissue	T024	C0040300
27579316	413	420	samples	T167	C0370003
27579316	426	433	healthy	T080	C3898900
27579316	434	445	individuals	T098	C0237401
27579316	458	466	patients	T101	C0030705
27579316	472	487	degenerative AS	T047	C0003507
27579316	501	507	miRNAs	T028	C2825314
27579316	509	524	hsa-miR-193a-3p	T028	C1826007
27579316	526	542	hsa-miR-29b-1-5p	T028	C2825314
27579316	544	558	hsa-miR-505-5p	T028	C1826059
27579316	560	574	hsa-miR-194-5p	T028	C1537827
27579316	576	590	hsa-miR-99b-3p	T028	C2825314
27579316	596	611	hsa-miR-200b-3p	T028	C2825314
27579316	618	631	overexpressed	T045	C1514559
27579316	640	655	hsa-miR-3663-3p	T028	C3147923
27579316	657	672	hsa-miR-513a-5p	T028	C2825314
27579316	674	689	hsa-miR-146b-5p	T028	C2825314
27579316	691	703	hsa-miR-1972	T028	C2825314
27579316	705	716	hsa-miR-718	T028	C2829676
27579316	718	730	hsa-miR-3138	T028	C2829740
27579316	732	745	hsa-miR-21-5p	T028	C1537719
27579316	747	758	hsa-miR-630	T028	C1826209
27579316	760	771	hsa-miR-575	T028	C1826154
27579316	773	788	hsa-miR-301a-3p	T028	C1537865
27579316	790	801	hsa-miR-636	T028	C1826215
27579316	803	817	hsa-miR-34a-3p	T028	C2825314
27579316	819	832	hsa-miR-21-3p	T028	C1537719
27579316	838	853	hsa-miR-516a-5p	T028	C2825314
27579316	860	873	downregulated	T044	C0013081
27579316	877	883	aortic	T023	C0003483
27579316	884	890	tissue	T024	C0040300
27579316	896	898	AS	T047	C0003507
27579316	899	907	patients	T101	C0030705
27579316	909	924	GeneSpring 13.1	T170	C0242356
27579316	937	945	identify	T080	C0205396
27579316	946	955	potential	T080	C3245505
27579316	956	961	human	T016	C0086418
27579316	962	967	miRNA	T028	C2825314
27579316	968	974	target	T169	C1521840
27579316	975	980	genes	T028	C0017337
27579316	1016	1027	predictions	T078	C0681842
27579316	1033	1043	TargetScan	T170	C0242356
27579316	1045	1049	PITA	T170	C0242356
27579316	1055	1076	microRNAorg databases	T170	C0242356
27579316	1078	1091	Gene Ontology	T170	C1138831
27579316	1092	1096	(GO)	T170	C1138831
27579316	1101	1140	Kyoto Encyclopedia of Genes and Genomes	T170	C0242356
27579316	1141	1147	(KEGG)	T170	C0242356
27579316	1148	1156	analysis	T062	C0936012
27579316	1162	1171	performed	T169	C0884358
27579316	1175	1183	identify	T080	C0205396
27579316	1184	1193	potential	T080	C3245505
27579316	1194	1202	pathways	T044	C1704259
27579316	1207	1217	functional	T169	C0205245
27579316	1218	1229	annotations	T063	C2936606
27579316	1246	1248	AS	T047	C0003507
27579316	1257	1263	miRNAs	T028	C2825314
27579316	1298	1307	expressed	T045	C1515670
27579316	1316	1324	patients	T101	C0030705
27579316	1330	1332	AS	T047	C0003507
27579316	1333	1340	samples	T167	C0370003
27579316	1345	1351	normal	T080	C0205307
27579316	1352	1360	controls	T096	C0009932
27579316	1365	1375	identified	T080	C0205396
27579316	1376	1385	potential	T080	C3245505
27579316	1386	1391	miRNA	T028	C2825314
27579316	1392	1399	targets	T169	C1521840
27579316	1404	1422	molecular pathways	T044	C1704259
27579316	1444	1453	morbidity	T047	C1301700
27579316	1460	1465	study	T062	C2603343
27579316	1480	1485	miRNA	T028	C2825314
27579316	1486	1506	expression signature	T169	C1704864
27579316	1510	1525	degenerative AS	T047	C0003507
27579316	1542	1550	improved	T033	C0184511
27579316	1572	1594	molecular pathobiology	T091	C0026376
27579316	1603	1610	disease	T047	C0012634